ECP 2023 Final Programme

Tuesday, 12 Sept 58 Scientific Programme a Tuesday 004 15:30–15:45 Tissue biomarker evaluation in clinical trials design Reinhard Büttner, Germany 005 15:45–16:00 Digital pathology in clinical trials Yukako Yagi, USA 006 16:00–16:15 Pathology-driven clinical trials from the oncologists perspective; window of opportunity trials Antonio Llombart Cussac, Spain 007 16:15–16:30 Perspectives in education Abhik Mukherjee, United Kingdom 008 16:30–16:45 General Discussion SC-14 Short Course 14:45–16:45 Liffey A Molecular Pathology Pulmonary Pathology Joint Short Course: When the liquid biopsy meets the pathologists Chairs: Marius Ilié, France Fiorella Calabrese, Italy 001 14:45–15:15 ESMO recommendations for liquid biopsy testing and the use of liquid biopsy to monitor the response to therapy Nicola Normanno, Italy 002 15:15–15:45 Liquid biopsy in immuno-oncology Klaus Pantel, Germany 003 15:45–16:15 How can we integrate liquid biopsies for patients with lung cancer in the pathology lab? Fernando Lopez-Rios, Spain 004 16:15–16:45 Advantages and limitations of liquid biopsy versus tissue biopsy in thoracic oncology Paul Hofman, France VM-03 Videomicroscopy 14:45–16:45 Wicklow Hall 2 Dermatopathology Pitfalls in dermatopathology Chairs: Vasileia Damaskou, Greece Eduardo Calonje, United Kingdom 001 14:45–15:45 Cases from Ljubljana, Slovenia Bostjan Luzar, Slovenia 002 15:45–16:45 Cases from Tours, France Thibault Kervarrec, France SY-14 Symposium 14:45–16:45 Liffey Hall 2 Paediatric and Perinatal Pathology Update in paediatric liver pathology Chairs: Rita Alaggio, Italy Maureen O’Sullivan, Ireland 001 14:45–15:05 Update on neonatal cholestasis Catherine Guettier, France 002 15:05–15:25 Autoimmune liver disease in children Jens Stahlschmidt, United Kingdom 003 15:25–15:45 Liver and haemopathies in children Paola Francalanci, Italy 004 15:45–16:05 Biology of hepatoblastoma Jessica Zucman-Rossi, France 005 16:05–16:25 Malignant hepatocellular neoplasm NOS Dolores López-Terrada, USA 006 16:25–16:45 Q&A